|
Market Closed -
Nasdaq
06:00:00 28/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 807.71 USD | -0.87% |
|
-3.94% | +4.64% |
| 27/08 | AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial | RE |
| 25/08 | Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients | MT |
| Market Cap | 81.36B 69.82B 65.41B 59.84B 113B 7,772B 113B 773B 302B 3,917B 305B 299B 12,965B | P/E 2026 * |
18.7x | P/E 2027 * | 16x |
|---|---|---|---|---|---|
| Enterprise Value | 74.49B 63.92B 59.89B 54.79B 103B 7,116B 104B 708B 277B 3,586B 280B 274B 11,870B | EV / Sales 2026 * |
4.4x | EV / Sales 2027 * | 3.84x |
| Free-Float |
71.06% | Yield 2026 * |
0.48% | Yield 2027 * | 0.55% |
Last Transcript : Regeneron Pharmaceuticals, Inc.
| 1 day | -0.87% | ||
| 1 week | -3.94% | ||
| Current month | +5.91% | ||
| 1 month | +23.12% | ||
| 3 months | +27.27% | ||
| 6 months | +4.79% | ||
| Current year | +4.64% |
| 1 week | 804.27 |  | 847 |
| 1 month | 676.46 | | 847 |
| Current year | 591.52 | | 847 |
| 1 year | 541 | | 847 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/8/26 | Fiscal year | General Counsel | 33,583 | 0.0326% | ||
| 18/8/26 | Fiscal year | Chief Financial Officer | 17,165 | 0.0167% | ||
| 10/8/26 | Fiscal year | Director | 1,200 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.87% | -3.94% | +37.45% | -2.73% | 81.36B | |
| -4.60% | -18.13% | +477.32% | +27.55% | 59.75B | |
| +0.84% | +4.44% | -19.19% | -35.11% | 59.19B | |
| +0.76% | +3.53% | +0.08% | +36.18% | 53.33B | |
| +0.41% | +1.88% | +11.09% | +171.67% | 49.09B | |
| +0.19% | -0.03% | +62.01% | -16.23% | 32.66B | |
| -0.30% | -0.57% | +52.07% | +100.03% | 25.97B | |
| -2.00% | +9.52% | +12.38% | +218.34% | 24.39B | |
| +0.78% | +0.47% | +61.53% | +123.40% | 16.91B | |
| -4.68% | +2.52% | -9.33% | +752.25% | 15.64B | |
| Average | -0.52% | +0.21% | +68.54% | +137.54% | 41.83B | |
| Weighted average by Cap. | -0.22% | -0.95% | +85.00% | +73.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.92B 14.52B 13.6B 12.45B 23.44B 1,616B 23.52B 161B 62.86B 815B 63.53B 62.15B 2,696B | 18.42B 15.8B 14.81B 13.55B 25.51B 1,759B 25.6B 175B 68.42B 887B 69.15B 67.65B 2,935B |
| Net income | 4.77B 4.1B 3.84B 3.51B 6.61B 456B 6.64B 45.37B 17.73B 230B 17.92B 17.53B 761B | 5.45B 4.67B 4.38B 4.01B 7.54B 520B 7.57B 51.75B 20.23B 262B 20.44B 20B 868B |
| Net Debt | -6.87B -5.89B -5.52B -5.05B -9.51B -656B -9.55B -65.28B -25.52B -331B -25.79B -25.23B -1,094B | -10.55B -9.06B -8.48B -7.76B -14.62B -1,008B -14.67B -100B -39.21B -508B -39.62B -38.76B -1,682B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/08/26 | USD 807.71 | -0.87% | 611,510 |
| 26/08/26 | USD 814.79 | -2.25% | 585,370 |
| 25/08/26 | USD 833.56 | +0.61% | 505,424 |
| 24/08/26 | USD 828.50 | -0.66% | 672,012 |
| 21/08/26 | USD 834.04 | +0.90% | 786,921 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
